MedDataX Logo

Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

NCT ID: NCT00847548

Last Updated: 2013-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intimate partner violence is a significant societal problem. However, treatment of IPV perpetrators is far from effective, which may be partly due to the fact that the role of substance abuse is not taken into account. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, perpetrators of intimate partner violence with substance use disorders enrolled in domestic violence treatment will be randomly assigned to either standard treatment for offenders of domestic violence or a combination of the latter treatment with cognitive-behavioral therapy addressing substance abuse (combined treatment).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Domestic Violence Substance Abuse

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

intimate partner violence domestic violence substance abuse alcohol abuse drug abuse addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

combined treatment

A combined treatment containing cognitive behavioral therapy addressing partner violence and cognitive behavioral therapy addressing substance abuse

Group Type EXPERIMENTAL

substance abuse/domestic violence treatment

Intervention Type BEHAVIORAL

This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse.

control condition

Cognitive behavioral therapy addressing partner violence

Group Type ACTIVE_COMPARATOR

CBT addressing partner violence

Intervention Type BEHAVIORAL

This treatment is comprised of 16 sessions of cognitive behavioral therapy addressing partner violence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

substance abuse/domestic violence treatment

This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse.

Intervention Type BEHAVIORAL

CBT addressing partner violence

This treatment is comprised of 16 sessions of cognitive behavioral therapy addressing partner violence.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A history of perpetration of intimate partner violence
* Current alcohol, cannabis and/or cocaine abuse or dependence
* Still in an intimate relationship with the victim

Exclusion Criteria

* Not sufficient fluency in Dutch to complete treatment and measures
* (ab)use of crack cocaine and/or heroin
* In need of clinical detoxification
* Severe mental disorders, such as psychosis
* Severe cognitive disorders, such as Korsakoff's syndrome
* In treatment for other mental health problems
* Abuse of children
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VU University of Amsterdam

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul M.G.Emmelkamp

Prof. Dr. P.M.G. Emmelkamp

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul M.G. Emmelkamp, PhD.

Role: PRINCIPAL_INVESTIGATOR

University of Amsterdam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

De Waag Amsterdam & Rijnmond

Amsterdam / Rotterdam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008-KP-463

Identifier Type: -

Identifier Source: org_study_id